PB2146: A PHASE 2, OPEN-LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) IN PREVIOUSLY UNTREATED UNFIT/FRAIL PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (LOTIS-9)

ABSTRACT:

SUBMITTER: Westin J 

PROVIDER: S-EPMC9429019 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature